Login
$RNTZ
$4.07 -$0.03 (0.73%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventories
Contract assets
Deposits, prepayments and other receivables
Total current assets
Non-current assets:
Property and equipment, net
Right-of-use assets, net
Intangible assets
Total non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Amounts due to related parties
Related Party
Total amounts due to related parties
Bank borrowings
Contract liabilities
Finance lease liabilities
Operating lease liabilities
Income tax payable
Total current liabilities
Long-term liabilities:
Bank borrowings
Finance lease liabilities
Operating lease liabilities
Deferred tax liabilities
Total long-term liabilities
TOTAL LIABILITIES
Shareholders’ equity
Ordinary share, par value US$0.00025, 2,000,000,000 shares authorized, 18,750,000 ordinary shares issued and outstanding, 15,625,000 ordinary shares issued and outstanding as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
(Accumulated losses) Retained earnings
Total shareholders’ equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support